Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Videos

Iliac Artery Stent Dislodgement: A Rare Transcatheter Aortic Valve Implantation Complication

Iosif Xenogiannis, PhD; Grigoris V. Karamasis, MD, FESC, FACC; Ioannis Lianos, PhD; Danny Dvir, PhD; Andreas S Kalogeropoulos, PhD, FESC, FRCP

02/23/2024
Video 1. Dislodged iliac artery stent drifted by the Navitor system over the SAFARI2 guidewire.
Video 2. The snare with the guidewire and the entrapped stent were then pulled back as a single unit, allowing the successful retrieval of the stent
Video 3. Final digital subtracted angiography (DSE) did not show any right iliac artery contrast extravasation or anatomy disruption

 

Video Supplement to "Iliac Artery Stent Dislodgement: A Rare Transcatheter Aortic Valve Implantation Complication" (Clinical Image).


Related Content

Clinical Images
Role of Diastology in Transcatheter Aortic Valve Implantation
02/24/2018
Transient elevation of LV diastolic pressure above LA pressure can occur in severe aortic regurgitation in the diastasis phase. Mitral E wave reversal in such a situation could serve as non-invasive evidence of elevated left ventricular...
Transient elevation of LV diastolic pressure above LA pressure can occur in severe aortic regurgitation in the diastasis phase. Mitral E wave reversal in such a situation could serve as non-invasive evidence of elevated left ventricular...
Transient elevation of LV...
02/24/2018
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

Scaffolds for BTK
Late-Breaking Data Shows Sustained Benefits of Abbott's Esprit™ BTK System for People Battling PAD Below the Knee
11/04/2024
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a...
11/04/2024
Cath Lab Digest
elective surgery post MI
Researchers Identify 'Sweet Spot' for Safe Surgery After Heart Attack
11/04/2024
"The data physicians are using for patient care decisions today is outdated. Given the advances in care and the ever-changing mix of patients, clinicians need the latest information," said Laurent Glance, MD. The recommendation was based on a...
"The data physicians are using for patient care decisions today is outdated. Given the advances in care and the ever-changing mix of patients, clinicians need the latest information," said Laurent Glance, MD. The recommendation was based on a...
"The data physicians are using...
11/04/2024
Cath Lab Digest
reimbursement
Elucid Announces CCTA Reimbursement to Be Doubled With CMS Rule
11/04/2024
Those decisions further recognize the importance of new technologies like Elucid’s PlaqueIQ™ that can help non-invasively quantify and classify coronary artery plaque and its components such as lipid-rich necrotic core (LRNC), giving...
Those decisions further recognize the importance of new technologies like Elucid’s PlaqueIQ™ that can help non-invasively quantify and classify coronary artery plaque and its components such as lipid-rich necrotic core (LRNC), giving...
Those decisions further...
11/04/2024
Cath Lab Digest
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
IVL + Laser Atherectomy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single Device to Treat PAD
11/04/2024
Royal Philips announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips that integrates two critical...
Royal Philips announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips that integrates two critical...
Royal Philips announced...
11/04/2024
Cath Lab Digest
Renal Denervation
Recor Medical Announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
11/04/2024
The Paradise uRDN system is an ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is an ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is an...
11/04/2024
Cath Lab Digest
Bioresorbable Scaffolds
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of Its Magnitude Drug-Eluting Next-Generation Bioresorbable Scaffold for BTK PAD
11/04/2024
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “This is a much-anticipated trial given the advancements and advantages of this next-generation technology which has the potential to transform the field of...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “This is a much-anticipated trial given the advancements and advantages of this next-generation technology which has the potential to transform the field of...
Eric A. Secemsky, MD, MSc, lead...
11/04/2024
Cath Lab Digest
reimbursement
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
11/04/2024
From one single test, CCTA provides a comprehensive view of a patient’s CAD and guides treatment planning when combined with HeartFlow fractional flow reserve computed tomography (FFRCT) and Plaque Analysis.
From one single test, CCTA provides a comprehensive view of a patient’s CAD and guides treatment planning when combined with HeartFlow fractional flow reserve computed tomography (FFRCT) and Plaque Analysis.
From one single test, CCTA...
11/04/2024
Cath Lab Digest
renal denervation
CMS Grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral Renal Denervation Catheter
11/04/2024
CMS has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral™ renal denervation catheter, used in the Symplicity™ blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT...
CMS has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral™ renal denervation catheter, used in the Symplicity™ blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT...
CMS has granted transitional...
11/04/2024
Cath Lab Digest
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Clinical Images
Percutaneous Closure of Pulmonary Arteriovenous Malformation and Concomitant Patent Foramen Ovale for Cryptogenic Stroke
11/04/2024
A 64-year-old woman presented with acute onset left-sided facial droop, left upper extremity paresis, and aphasia. Magnetic resonance imaging demonstrated acute infarction of the right thalamus.
A 64-year-old woman presented with acute onset left-sided facial droop, left upper extremity paresis, and aphasia. Magnetic resonance imaging demonstrated acute infarction of the right thalamus.
A 64-year-old woman presented...
11/04/2024
Journal of Invasive Cardiology
Scaffolds for BTK
Late-Breaking Data Shows Sustained Benefits of Abbott's Esprit™ BTK System for People Battling PAD Below the Knee
11/04/2024
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a...
11/04/2024
Cath Lab Digest
elective surgery post MI
Researchers Identify 'Sweet Spot' for Safe Surgery After Heart Attack
11/04/2024
"The data physicians are using for patient care decisions today is outdated. Given the advances in care and the ever-changing mix of patients, clinicians need the latest information," said Laurent Glance, MD. The recommendation was based on a...
"The data physicians are using for patient care decisions today is outdated. Given the advances in care and the ever-changing mix of patients, clinicians need the latest information," said Laurent Glance, MD. The recommendation was based on a...
"The data physicians are using...
11/04/2024
Cath Lab Digest
reimbursement
Elucid Announces CCTA Reimbursement to Be Doubled With CMS Rule
11/04/2024
Those decisions further recognize the importance of new technologies like Elucid’s PlaqueIQ™ that can help non-invasively quantify and classify coronary artery plaque and its components such as lipid-rich necrotic core (LRNC), giving...
Those decisions further recognize the importance of new technologies like Elucid’s PlaqueIQ™ that can help non-invasively quantify and classify coronary artery plaque and its components such as lipid-rich necrotic core (LRNC), giving...
Those decisions further...
11/04/2024
Cath Lab Digest
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
IVL + Laser Atherectomy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single Device to Treat PAD
11/04/2024
Royal Philips announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips that integrates two critical...
Royal Philips announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips that integrates two critical...
Royal Philips announced...
11/04/2024
Cath Lab Digest
Renal Denervation
Recor Medical Announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
11/04/2024
The Paradise uRDN system is an ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is an ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is an...
11/04/2024
Cath Lab Digest
Bioresorbable Scaffolds
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of Its Magnitude Drug-Eluting Next-Generation Bioresorbable Scaffold for BTK PAD
11/04/2024
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “This is a much-anticipated trial given the advancements and advantages of this next-generation technology which has the potential to transform the field of...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “This is a much-anticipated trial given the advancements and advantages of this next-generation technology which has the potential to transform the field of...
Eric A. Secemsky, MD, MSc, lead...
11/04/2024
Cath Lab Digest
reimbursement
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
11/04/2024
From one single test, CCTA provides a comprehensive view of a patient’s CAD and guides treatment planning when combined with HeartFlow fractional flow reserve computed tomography (FFRCT) and Plaque Analysis.
From one single test, CCTA provides a comprehensive view of a patient’s CAD and guides treatment planning when combined with HeartFlow fractional flow reserve computed tomography (FFRCT) and Plaque Analysis.
From one single test, CCTA...
11/04/2024
Cath Lab Digest
renal denervation
CMS Grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral Renal Denervation Catheter
11/04/2024
CMS has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral™ renal denervation catheter, used in the Symplicity™ blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT...
CMS has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral™ renal denervation catheter, used in the Symplicity™ blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT...
CMS has granted transitional...
11/04/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement